- SG$201.32m
- SG$198.01m
- SG$74.20m
- 85
- 44
- 52
- 68
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.17 | ||
| Price to Tang. Book | 5.05 | ||
| Price to Free Cashflow | 25.84 | ||
| Price to Sales | 2.68 | ||
| EV to EBITDA | 9.29 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.92% | ||
| Return on Equity | 14.45% | ||
| Operating Margin | 23.53% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | 36.33 | 40.47 | 62.95 | 69.99 | 74.2 | n/a | n/a | 11.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -39.28 | +25.52 | +86.22 | +0.71 | +7.39 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ISEC Healthcare Ltd. is an investment holding company. The Company is a provider of a comprehensive suite of medical eye care services with ambulatory surgical centers. It provides a full range of tertiary specialty services, ranging from laser eye surgery to vitreoretinal, orbital reconstruction and complex corneal transplantation surgery. It operates through two segments: Specialized health services and General health services. Specialized health services are engaged in the provision of medical care, consultancy, treatment, and surgery in the field of ophthalmology. The General health services are engaged in the provision of general medical and procedural treatment services. The Company provides a range of tertiary specialty ophthalmology services at each of its locations and the services, such as cataract and intraocular lens implants, refractive surgery, retinal detachment surgery, adult strabismus and pediatric ophthalmology, oculoplastic, facial cosmetics, and aesthetics surgery.
Directors
- Weng Hoe Chong NEC (57)
- Jun Shyan Wong CEO (54)
- Yu Ting Low CFO (34)
- Alan Ang OTH (42)
- Yee Fong Choong OTH (45)
- Seng Kheong Fang OTH (53)
- Kim Chuan Yeo OTH (54)
- Kuan Loong Lai SEC
- Hung Ming Lee DRC (51)
- Bang Chen NED (55)
- Li Li NED (55)
- Yongmei Zhang NED (39)
- Wee Hann Lim IND (48)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- January 2nd, 2014
- Public Since
- October 28th, 2014
- No. of Shareholders
- 300
- No. of Employees
- 287
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Singapore Exchange Securities Trading Ltd- Shares in Issue
- 575,193,052
- Address
- 51 Goldhill Plaza, #10-07/08, 308900
- Web
- https://www.isechealthcare.com/
- Phone
- +65 62582262
- Auditors
- Forvis Mazars LLP
Upcoming Events for 40T
Q3 2025 ISEC Healthcare Ltd Earnings Release
Similar to 40T
Alliance Healthcare
Singapore Exchange Securities Trading Ltd
Aoxin Q & M Dental
Singapore Exchange Securities Trading Ltd
Asiamedic
Singapore Exchange Securities Trading Ltd
Asia Vets Holdings
Singapore Exchange Securities Trading Ltd
Beverly JCG
Singapore Exchange Securities Trading Ltd
FAQ
What is the ISEC Healthcare share price?
As of Today at 21:22 UTC, shares in ISEC Healthcare are trading at SG$0.35. This share price information is delayed by 15 minutes.
How has the ISEC Healthcare share price performed this year?
Shares in ISEC Healthcare last closed at SG$0.35 and the price had moved by -9.09% over the past 365 days. In terms of relative price strength the ISEC Healthcare share price has underperformed the FTSE Developed Asia Pacific Index by -8.05% over the past year.
What are the analyst and broker recommendations for ISEC Healthcare?
There is no consensus recommendation for this security.
Find out moreWhat is the ISEC Healthcare dividend yield?
The ISEC Healthcare dividend yield is 2.86% based on the trailing twelve month period.
Does ISEC Healthcare pay a dividend?
Last year, ISEC Healthcare paid a total dividend of SG$0.01, and it currently has a trailing dividend yield of 2.86%.Looking ahead, shares in ISEC Healthcare are due to go ex-dividend on 2025-04-28 and the next dividend pay date is 2025-05-09.
When does ISEC Healthcare next pay dividends?
ISEC Healthcare are due to go ex-dividend on 2025-04-28 and the next dividend pay date is 2025-05-09. The historic dividend yield on ISEC Healthcare shares is currently 2.86%.
How do I buy ISEC Healthcare shares?
To buy shares in ISEC Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of ISEC Healthcare?
As of the previous close price of SG$0.35, shares in ISEC Healthcare had a market capitalisation of SG$201.32m.
Where are ISEC Healthcare shares listed?
Here are the trading details for ISEC Healthcare:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: 40T
What kind of share is ISEC Healthcare?
Based on an overall assessment of its quality, value and momentum ISEC Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a ISEC Healthcare share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the ISEC Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ISEC Healthcare. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -4.91%.
As of the last closing price of SG$0.35, shares in ISEC Healthcare were trading -15.3% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the ISEC Healthcare PE Ratio?
The ISEC Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SG$0.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of ISEC Healthcare?
ISEC Healthcare's management team is headed by:
- Weng Hoe Chong - NEC
- Jun Shyan Wong - CEO
- Yu Ting Low - CFO
- Alan Ang - OTH
- Yee Fong Choong - OTH
- Seng Kheong Fang - OTH
- Kim Chuan Yeo - OTH
- Kuan Loong Lai - SEC
- Hung Ming Lee - DRC
- Bang Chen - NED
- Li Li - NED
- Yongmei Zhang - NED
- Wee Hann Lim - IND